AI-Assisted Diagnostics

OncoFirm™ Diagnostics is investigating AI-assisted diagnostic technologies as part of its research and development platform for cancer biomarker testing. By combining fluorescence-based assay data with digital signal processing, statistical modeling, and machine-learning methods, OncoFirm aims to evaluate whether computational tools can improve signal interpretation, quality assessment, reproducibility, and multi-biomarker analysis. These technologies remain under development and are intended to support research and future regulated diagnostic applications subject to appropriate analytical validation, clinical evaluation, and applicable FDA authorization.